MinaNikanjamMD

PubMed

• Critical insights into the evolving drug-approval process in China.
  Nikanjam, M., Kurzrock, R.> ;Cancer. 2024 Mar 1
• Brief Report: Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum.
  Jeremiah D Momper, Mina Nikanjam, Brookie M Best, Mark Mirochnick, Edmund V Capparelli, Tim R Cressey> ;Journal of Acquired Immune Deficiency Syndromes. 2023 Dec 1
• At the right dose: personalised (N-of-1) dosing for precision oncology.
  Mina Nikanjam, Shumei Kato, Jason K Sicklick, Razelle Kurzrock> ;European Journal of Cancer. 2023 Nov 1
• Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in Regular Users.
  Marlon Liyanage, Mina Nikanjam, Edmund V Capparelli, Raymond T Suhandynata, Robert L Fitzgerald, Thomas D Marcotte, Igor Grant, Jeremiah D Momper> ;Therapeutic Drug Monitoring. 2023 Oct 1
• 2 citations
  Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego.
  Mina Nikanjam, Jose Tinajero, Mary McGann, Jerry Li, Jincheng Yang, Felicity Shen, Jason K Sicklick, Shumei Kato, Edmund Capparelli, Razelle Kurzrock> ;Journal of Hematology Oncology Pharmacy. 2023 Feb 1
• Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach.
  Joseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, Chelsea L Blaquera, Scott R Penzak, Thomas D Nolin, Mary F Paine, Joseph D Ma> ;Therapeutic Drug Monitoring. 2023 Aug 1
• 1 citations
  Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken.
  Mina Nikanjam, Shumei Kato, Razelle Kurzrock> ;Journal of Immunotherapy and Precision Oncology. 2022 Nov 1
• 121 citations
  Liquid biopsy: current technology and clinical applications.
  Mina Nikanjam, Shumei Kato, Razelle Kurzrock> ;Journal of Hematology & Oncology. 2022 Sep 12
• 1 citations
  Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case series.
  Mina Nikanjam, Jaren Mullen, Carol Yacoub, Gregory A Daniels> ;Journal of Medical Case Reports. 2022 Aug 31
• 2 citations
  Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age.
  Mina Nikanjam, Lana Tran, Ellen G Chadwick, Mutsa Bwakura-Dangarembizi, Carolyn Bolton Moore, Pearl Samson, Stephen A Spector, Nahida Chakhtoura, Patrick Jean-Philippe...> ;AIDS. 2022 Mar 15
• 1 citations
  Cetuximab in Patients with Non-Small Cell Lung Cancer and EGFR Exon 20 Insertion Alterations.
  Mina Nikanjam, Shumei Kato, Jacob J Adashek, Razelle Kurzrock> ;Clinical Oncology, Case Reports. 2022 Jan 1
• 4 citations
  Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling and Simulation.
  Joseph Piscitelli, Mina Nikanjam, Brookie M. Best, Edward P. Acosta, Mark Mirochnick, Diana F Clarke, Edmund V. Capparelli, Jeremiah D. Momper> ;Journal of Acquired Immune Deficiency Syndromes. 2021 Oct 6
• 34 citations
  Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
  Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta, Michael E. Hahn, Pradip De, Casey Williams, Jessica Guido, Benjamin M. S...> ;Genome Medicine. 2021 Oct 4
• 1 citations
  S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults
  Lana Tran, Mina Nikanjam, Edmund V. Capparelli, Joseph S. Bertino, Anne N. Nafziger, Angela D. M. Kashuba, Sandrine Turpault, Joseph D. Ma> ;European Journal of Clinical Pharmacology. 2021 Mar 23
• 3 citations
  BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes.
  Mina Nikanjam, Jose Tinajero, Donald A. Barkauskas, Razelle Kurzrock> ;Molecular Cancer Therapeutics. 2021 Mar 15
• 24 citations
  Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.
  Lindsey M. Charo, Ramez N. Eskander, Ryosuke Okamura, Sandip Pravin Patel, Mina Nikanjam, Richard B. Lanman, David Piccioni, Shumei Kato, Michael T. McHale, Razelle Ku...> ;Molecular Oncology. 2021 Jan 1
• 5 citations
  Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach.
  Jerry Li, Mina Nikanjam, Coleen K. Cunningham, Elizabeth J. McFarland, Emily E. Coates, Katherine V. Houser, Bob C. Lin, Adrian B. McDermott, Britta Flach, Lucio Gama,...> ;Clinical Pharmacology and Therapeutics. 2021 Jan 1
• 7 citations
  Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients.
  Amin Haghighat Jahromi, Donald A. Barkauskas, Matthew Zabel, Aaron M. Goodman, G.M. Frampton, Mina Nikanjam, Carl K. Hoh, Razelle Kurzrock> ;EJNMMI Research. 2020 Dec 9
• 148 citations
  Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
  Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amélie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis John Kuo, Ramez N. Eskander, Aaron M. Goodman, Natalie Galanina, Paul ...> ;Nature Communications. 2020 Oct 2
• 1 citations
  Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy.
  Philip R. Cohen, Mina Nikanjam, Shumei Kato, Aaron M. Goodman, Razelle Kurzrock> ;Cureus. 2020 Jul 2
• 7 citations
  Tumor mutational burden is not predictive of cytotoxic chemotherapy response.
  Mina Nikanjam, Paul Riviere, Aaron M. Goodman, Donald A. Barkauskas, Garrett M. Frampton, Razelle Kurzrock> ;Oncoimmunology. 2020 Jun 24
• 19 citations
  Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients
  Mina Nikanjam, David Arguello, Zoran Gatalica, Jeff Swensen, Donald A. Barkauskas, Razelle Kurzrock> ;International Journal of Cancer. 2020 Jun 1
• 255 citations
  Review of precision cancer medicine: Evolution of the treatment paradigm.
  Apostolia Maria Tsimberidou, Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock> ;Cancer Treatment Reviews. 2020 Mar 31
• 12 citations
  Targeting fusions for improved outcomes in oncology treatment
  Mina Nikanjam, Ryosuke Okamura, Donald A. Barkauskas, Razelle Kurzrock> ;Cancer. 2020 Mar 15
• 34 citations
  Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity.
  Shumei Kato, Ryosuke Okamura, Yuichi Kumaki, Sadakatsu Ikeda, Mina Nikanjam, Ramez N. Eskander, Aaron M. Goodman, Suzanna Lee, Sean T. Glenn, Devin Dressman, Antonios ...> ;Oncoimmunology. 2020 Feb 17
• Join now to see all